Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
i-PRF for Maxillary Canine Retraction
NCT05429437Phase 1Unknown
- Sponsor
- Al-Azhar University
- Start
- Nov 2022
- Primary completion
- Mar 2023
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1 trial of platelet rich fibrin in malocclusion, sponsored by Al-Azhar University. Primary endpoint: Acceleration of maxillary canine retraction at 4 months. Status: unknown.
02
Drugs
platelet rich fibrin
03
Conditions
malocclusion
Beyond the preview
Go deeper on NCT05429437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05429437.